|
Market Closed -
NYSE
04:02:46 20/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 153.29 USD | -0.63% |
|
-0.21% | +56.82% |
| 03:01pm | As weight-loss drug users turn to dietary supplements, doctors, regulators raise flags | RE |
| 10-16 | Target Says Pricing Not Based on Shopper Identity or Location Data | MT |
Company Valuation: Target Corporation
Data adjusted to current consolidation scope
| Fiscal Period: January | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 105,613 | 79,238 | 64,208 | 63,192 | 47,757 | 69,639 | - | - |
| Change | - | -24.97% | -18.97% | -1.58% | -24.42% | 45.82% | - | - |
| Enterprise Value (EV) 1 | 113,422 | 93,148 | 76,441 | 74,370 | 58,725 | 80,594 | 80,127 | 79,489 |
| Change | - | -17.88% | -17.94% | -2.71% | -21.04% | 37.24% | -0.58% | -0.8% |
| P/E | 15.6x | 28.8x | 15.6x | 15.6x | 13x | 14.7x | 16.1x | 15.1x |
| PBR | 8.1x | 7.06x | 4.78x | 4.28x | 2.95x | 3.76x | 3.38x | 3.01x |
| PEG | - | -0.5x | 0.3x | -17.43x | -1.58x | 0.5x | -1.84x | 2.23x |
| Capitalization / Revenue | 1x | 0.73x | 0.6x | 0.59x | 0.46x | 0.63x | 0.61x | 0.59x |
| EV / Revenue | 1.07x | 0.85x | 0.71x | 0.7x | 0.56x | 0.73x | 0.7x | 0.68x |
| EV / EBITDA | 9.48x | 14.1x | 8.89x | 8.59x | 7.43x | 8.41x | 8.62x | 8.11x |
| EV / EBIT | 12.2x | 23.9x | 13.4x | 13.4x | 12.3x | 12.4x | 13.4x | 12.5x |
| EV / FCF | 22.3x | -61.7x | 20x | 16.6x | 20.7x | 25.8x | 28.1x | 24.1x |
| FCF Yield | 4.48% | -1.62% | 4.99% | 6.02% | 4.83% | 3.88% | 3.56% | 4.16% |
| Dividend per Share 2 | 3.38 | 4.14 | 4.38 | 4.46 | 4.54 | 4.568 | 4.608 | 4.851 |
| Rate of return | 1.53% | 2.41% | 3.15% | 3.23% | 4.3% | 2.98% | 3.01% | 3.16% |
| EPS 2 | 14.1 | 5.98 | 8.94 | 8.86 | 8.13 | 10.42 | 9.512 | 10.16 |
| Distribution rate | 24% | 69.2% | 49% | 50.3% | 55.8% | 43.8% | 48.4% | 47.8% |
| Net sales 1 | 106,005 | 109,120 | 107,412 | 106,566 | 104,780 | 110,193 | 113,829 | 117,382 |
| EBITDA 1 | 11,970 | 6,596 | 8,600 | 8,653 | 7,909 | 9,579 | 9,294 | 9,802 |
| EBIT 1 | 9,328 | 3,896 | 5,707 | 5,566 | 4,775 | 6,480 | 5,982 | 6,359 |
| Net income 1 | 6,946 | 2,780 | 4,138 | 4,091 | 3,705 | 4,741 | 4,311 | 4,495 |
| Net Debt 1 | 7,809 | 13,910 | 12,233 | 11,178 | 10,968 | 10,955 | 10,488 | 9,850 |
| Reference price 2 | 220.43 | 172.14 | 139.08 | 137.91 | 105.47 | 153.29 | 153.29 | 153.29 |
| Nbr of stocks (in thousands) | 479,124 | 460,310 | 461,662 | 458,212 | 452,806 | 454,297 | - | - |
| Announcement Date | 1/3/22 | 28/2/23 | 5/3/24 | 4/3/25 | 3/3/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 14.7x | 0.73x | 8.41x | 2.98% | 69.64B | |
| 43.66x | 1.29x | 26.66x | 0.62% | 441B | |
| 27.7x | 2.47x | 17.59x | 1.28% | 162B | |
| 16.74x | 0.88x | 8.8x | 3.05% | 46.8B | |
| 39.67x | 7.3x | 22.86x | 0.23% | 39.14B | |
| 16.85x | 0.73x | 9.07x | 1.79% | 29.4B | |
| 15.46x | 1.43x | 10.62x | -.--% | 23.11B | |
| 19.14x | 0.87x | 9.78x | 1.37% | 13.95B | |
| 21.8x | 0.66x | 12.64x | -.--% | 12.96B | |
| 13.22x | 0.5x | 7.63x | 2.84% | 8.88B | |
| Average | 22.89x | 1.68x | 13.41x | 1.42% | 84.71B | |
| Weighted average by Cap. | 33.79x | 1.68x | 20.52x | 1.11% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- TGT Stock
- Valuation Target Corporation
Select your edition
All financial news and data tailored to specific country editions
